LL, yes I largely agree. Any sov state holds a lot of cards and that's true here ; tho they will be keen to progress the development they will want their slice of upfront cake, as well as the ongoing employment/taxation and spin off benefits of the project once up and running.
And ALL needs a bit more cash too, so this imv is the obstacle to a much higher valuation. I suspect all these issues will resolve at one fell swoop, the unknown is how far existing holdrs might be diluted, which is giving many pause, including me.
As ever, we shall have to wait and see.
This is an impressive level of director buying.
I am sitting on the sidelines for now awaiting the Ghana SWF buy inand confirmation of the final piece of the funding jigsaw.
But..../ this level of director confidence is tempting me to dip my toe in early.
As someone points out on another thread, this is a sound divi payer which should not just return a steady divi, but as and when rates trend lower should appreciate, too.
It is not one of those get rich quick scheme where the BB is infested with talk of ramping and deramping, and I suggest anyone here talking of such is best ignored. As are obscure Latin quotations, which tell us nothing about the company but, quite intentionally, everything about the ego of the poster.
Maestro, u seem to be missing Oak's point. Which is that regardles of today's known facts, Orca could come back with more damaging allegations now they have prey in their sights, indeed their strategy could almost compel it.
I too am tempted at this level, but caveat emptor, the sharks are in the water and I for one ain't jumping in till they're gone.
"someone will then take out the whole company for a nice premium at that time"
Probably. But having shafted holders once, do you imagine they'll not get shafted again?
If you pull a stunt like this once, you've got an endgame in mind, and I'll wager the Bod and large holders will grab any gains. There are ways, and they're easier in a less liquid market. Having delisted once, what will stop them delisting on ASX and going private?
Happemed at JKX once they saw the money, tho at least they got screwed over themselves by VVP in the end.
TT, I tend to agree. Anyone trading this share now better know what they are doing.
he will comment in due course 4 sure. the issue here is trading ASX , and liquidity, in the short term.
LT tho, the more serious issue is that BoD credibility is destroyed. Who wants to invest with directors who have not just manahed to screw up a fabulous asset (I refer to the holdings in SFT, and the NSRs) by getting caught out with financial instruments and other investee companies, but on top of that shown willing to screw over their UK shareholders?
Dreadful reading. To get caught on the wrong side of financing as a forced seller tells me that the Bod are not smart enough to be playing with complex debt indtruments like collared loan facilities, etcs, together with modelling future cash calls from investee cos.
tempting to sell and get out when the Bod tests ypur confidence in them, but i will hold.
Bcos it's not that long b4 Motheo starts up, and the royalties from that once flowingshould be transformative not just for revenues but also NAV.
Fingers xd the Bod can be patient, and not rush into some smart**** forward finance/investments that erodes their value.
I doubt it, far too soon after the last one. There is even a chance of avoiding any future placings, tho that will depend on offtaker interest and available finance for the coke batteries.
I like Myles' analysis but you're quite right he keeps pretty quiet when he sells out.
Tbf tho, if he has sold here, it willl, I think, only be his ST trading PF, not his LT holding. If anyone is sold on AVCT LT potential, it seems to be Myles.
But as always, dyor, and remember LT convivtion buys can be a longer time coming than thought. They can also be wrong. Uncertainty is the name of the game with early pharma/bio, whatever anyone says.
Perhaps you could share with us your qualification and experience to pass this judgement , ,
CEOs of cos like this have multiple objectives to pursue, sometimes complementary, others contradictory, all of them challenging. Either trust the BoD or bail out.
Mr, you will get nowhere refrring to fellow investors as morons, simply bcos they don't share your strong views.
And you are, imho, focusing on the wrong things.
I've seen nobody....nobody at all....suggesting any doubt overthe therapy or the platform. It clearly works, and it seems unlikely any srious side effects will emerge.
There are now questions of commerciality, of timelines and cash burn, and of comparison to other therapeutic approaches which might compete with, outperform, or simply get developed faster. i don't know the answer to those questions, and nor, as yet, does anyone else.
The sensible approach, it seems to me, is to be aware of those uncertainties, and make your best judgement as to whether they make a Mcap of £400m fair, cheap, or overvalued.
Nobody knows, so don't rubbish those who take different views to yourself on the balance of risk.
Mr, you will get nowhere refrring to fellow investors as morons, simply bcos they don't share your strong views.
And you are, imho, focusing on the wrong things.
I've seen nobody....nobody at all....suggesting any doubt overthe therapy or the platform. It clearly works, and it seems unlikely any srious side effects will emerge.
There are now questions of commerciality, of timelines and cash burn, and of comparison to other therapeutic approaches which might compete with, outperform, or simply get developed faster. i don't know the answer to those questions, and nor, as yet, does anyone else.
The sensible approach, it seems to me, is to be aware of those uncertainties, and make your best judgement as to whether they make a Mcap of £400m fair, cheap, or overvalued.
Nobody knows, so don't rubbish those who take different views to yourself on the balance of risk.